BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38146008)

  • 21. USP30 impairs mitochondrial quality control and aggravates oxidative damage after traumatic brain injury.
    Wu Y; Hu Q; Cheng H; Yu J; Gao L; Gao G
    Biochem Biophys Res Commun; 2023 Sep; 671():58-66. PubMed ID: 37300943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.
    Rasoolnezhad M; Safaralizadeh R; Hosseinpour Feizi MA; Banan-Khojasteh SM; Roshani Asl E; Lotfinejad P; Baradaran B
    Mol Biol Rep; 2023 Oct; 50(10):8407-8420. PubMed ID: 37620737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis.
    Wang YQ; Huang G; Chen J; Cao H; Xu WT
    Breast Cancer Res Treat; 2021 Jul; 188(1):1-14. PubMed ID: 33782812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Mitochondrial Deubiquitinase USP30 Regulates AKT/mTOR Signaling.
    Zhang R; Ozgen S; Luo H; Krigman J; Zhao Y; Xin G; Sun N
    Front Pharmacol; 2022; 13():816551. PubMed ID: 35250566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. USP30-AS1 contributes to mitochondrial quality control in glioblastoma cells.
    Wang N; Li J; Xin Q; Xu N
    Biochem Biophys Res Commun; 2021 Dec; 581():31-37. PubMed ID: 34653676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer.
    Li Z; Liu B; Li C; Sun S; Zhang H; Sun S; Wang Z; Zhang X
    Front Oncol; 2021; 11():634026. PubMed ID: 33816275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
    Yuen HF; Chan YK; Grills C; McCrudden CM; Gunasekharan V; Shi Z; Wong AS; Lappin TR; Chan KW; Fennell DA; Khoo US; Johnston PG; El-Tanani M
    J Pathol; 2011 May; 224(1):78-89. PubMed ID: 21404275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy.
    Bingol B; Tea JS; Phu L; Reichelt M; Bakalarski CE; Song Q; Foreman O; Kirkpatrick DS; Sheng M
    Nature; 2014 Jun; 510(7505):370-5. PubMed ID: 24896179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism and regulation of the Lys6-selective deubiquitinase USP30.
    Gersch M; Gladkova C; Schubert AF; Michel MA; Maslen S; Komander D
    Nat Struct Mol Biol; 2017 Nov; 24(11):920-930. PubMed ID: 28945249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
    Tao L; Wu YQ; Zhang SP
    Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ZNF746 promotes M2 macrophage polarisation and favours tumour progression in breast cancer via the Jagged1/Notch pathway.
    Liu L; Zhao WY; Zheng XY
    Cell Signal; 2023 Dec; 112():110892. PubMed ID: 37730102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway.
    Wang B; Chen H; Deng Y; Chen H; Xing L; Guo Y; Wang M; Chen J
    J Transl Med; 2023 Mar; 21(1):186. PubMed ID: 36895010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PAK1 promotes proliferation, migration and invasion of hepatocellular carcinoma by facilitating EMT via directly up-regulating Snail.
    Cao F; Yin LX
    Genomics; 2020 Jan; 112(1):694-702. PubMed ID: 31071459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
    Zhang Y; Tian J; Qu C; Peng Y; Lei J; Li K; Zong B; Sun L; Liu S
    Breast Cancer; 2021 Jul; 28(4):859-873. PubMed ID: 33569740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer.
    Li XM; Liu WL; Chen X; Wang YW; Shi DB; Zhang H; Ma RR; Liu HT; Guo XY; Hou F; Li M; Gao P
    Int J Mol Med; 2017 Apr; 39(4):927-935. PubMed ID: 28259959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone Methyltransferase SETD1A Induces Epithelial-Mesenchymal Transition to Promote Invasion and Metastasis Through Epigenetic Reprogramming of Snail in Gastric Cancer.
    Wu J; Chai H; Shan H; Pan C; Xu X; Dong W; Yu J; Gu Y
    Front Cell Dev Biol; 2021; 9():657888. PubMed ID: 34164392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin-Specific Protease 3 Promotes Glioblastoma Cell Invasion and Epithelial-Mesenchymal Transition via Stabilizing Snail.
    Fan L; Chen Z; Wu X; Cai X; Feng S; Lu J; Wang H; Liu N
    Mol Cancer Res; 2019 Oct; 17(10):1975-1984. PubMed ID: 31266817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL.
    Liu Y; Tang W; Yao F
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.